14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Jun 06, 2023 Buy 600 000 Kelly Steven Stock Option (Right to Buy)
Jun 06, 2023 Buy 38 700 Zweifach Sanford S Stock Option (Right to Buy)
Jun 06, 2023 Buy 238 000 Morris Richard Steven Stock Option (Right to Buy)
Jun 06, 2023 Buy 38 700 Torok Michael Stock Option (Right to Buy)
Jun 06, 2023 Buy 238 000 Klichinsky Michael Stock Option (Right to Buy)
Jun 06, 2023 Buy 38 700 Ugwumba Chidozie Stock Option (Right to Buy)
Jun 06, 2023 Buy 38 700 Morrison Briggs Stock Option (Right to Buy)
Mar 07, 2023 Buy 0 Modernatx, Inc. Common Stock
Mar 07, 2023 Buy 625 797 Kelly Steven Stock Option (Right to Buy)
Mar 07, 2023 Buy 415 968 Kelly Steven Stock Option (Right to Buy)
Mar 07, 2023 Buy 2 215 877 Ugwumba Chidozie Common Stock
Mar 07, 2023 Buy 2 297 546 Hodits Regina Common Stock
Mar 07, 2023 Buy 484 347 Klichinsky Michael Common Stock
Mar 07, 2023 Buy 112 064 Klichinsky Michael Stock Option (Right to Buy)
Mar 07, 2023 Buy 75 976 Klichinsky Michael Stock Option (Right to Buy)
Mar 07, 2023 Buy 56 982 Klichinsky Michael Stock Option (Right to Buy)
Mar 07, 2023 Buy 331 114 Morris Richard Steven Stock Option (Right to Buy)
Mar 07, 2023 Buy 319 991 Torok Michael Common Stock
Mar 07, 2023 Buy 51 250 Torok Michael Common Stock
Mar 07, 2023 Buy 50 000 Torok Michael Common Stock
Mar 07, 2023 Buy 184 621 Zweifach Sanford S Stock Option (Right to Buy)
Mar 07, 2023 Buy 413 Zweifach Sanford S Common stock
Mar 07, 2023 Buy 63 310 Morrison Briggs Stock Option (Right to Buy)
Mar 07, 2023 Buy 34 189 Morrison Briggs Stock Option (Right to Buy)
Mar 07, 2023 Buy 12 175 Morrison Briggs Common Stock
Mar 07, 2023 Buy 0 Kelly Steven
Mar 07, 2023 Buy 0 Ugwumba Chidozie
Mar 07, 2023 Buy 0 Hodits Regina
Mar 07, 2023 Buy 0 Klichinsky Michael
Mar 07, 2023 Buy 0 Morris Richard Steven
Mar 07, 2023 Buy 0 Torok Michael
Mar 07, 2023 Buy 0 Zweifach Sanford S
Mar 07, 2023 Buy 0 Odlander Bjorn
Mar 07, 2023 Buy 0 Morrison Briggs
Mar 02, 2023 Buy 113 175 Sullivan Mark Common Stock
Mar 02, 2023 Buy 185 000 Sullivan Mark Common Stock
Mar 02, 2023 Sell 44 879 Sullivan Mark Common Stock
Mar 02, 2023 Sell 73 361 Sullivan Mark Common Stock
Mar 02, 2023 Sell 100 978 Sullivan Mark Common Stock
Mar 02, 2023 Buy 102 975 Macdonald Glen C Common Stock
Mar 02, 2023 Sell 33 888 Macdonald Glen C Common Stock
Mar 02, 2023 Buy 183 317 Macdonald Glen C Common Stock
Mar 02, 2023 Sell 60 237 Macdonald Glen C Common Stock
Mar 02, 2023 Sell 76 247 Macdonald Glen C Common Stock
Mar 02, 2023 Sell 17 289 Ryu Elly Common Stock
Mar 02, 2023 Buy 606 800 Cannell Thomas R Common Stock
Mar 02, 2023 Sell 278 564 Cannell Thomas R Common Stock
Mar 02, 2023 Sell 208 923 Cannell Thomas R Common Stock
Mar 02, 2023 Buy 180 750 Forbes Monica Common Stock
Mar 02, 2023 Buy 190 375 Forbes Monica Common Stock
Mar 02, 2023 Sell 98 304 Forbes Monica Common Stock
Mar 02, 2023 Sell 93 279 Forbes Monica Common Stock
Mar 02, 2023 Sell 154 266 Forbes Monica Common Stock
Feb 21, 2023 Sell 39 831 Sullivan Mark Common Stock
Feb 21, 2023 Sell 7 159 Ryu Elly Common Stock
Feb 21, 2023 Sell 53 727 Cannell Thomas R Common Stock
Feb 21, 2023 Sell 61 862 Forbes Monica Common Stock
Feb 21, 2023 Sell 25 927 Macdonald Glen C Common Stock
Jun 22, 2022 Buy 65 000 Duker Jay S. Stock Option
Jun 22, 2022 Buy 40 000 Duker Jay S. Common Stock
Jun 22, 2022 Buy 65 000 Honig Peter Stock Option
Jun 22, 2022 Buy 65 000 Honig Peter Stock Option
Jun 22, 2022 Buy 40 000 Honig Peter Common Stock
Jun 22, 2022 Buy 40 000 Jewett Michael A. S. Common Stock
Jun 22, 2022 Buy 65 000 Keyes Jason A Stock Option
Jun 22, 2022 Buy 65 000 Keyes Jason A Stock Option
Jun 22, 2022 Buy 40 000 Keyes Jason A Common Stock
Jun 22, 2022 Buy 65 000 Bourdow Carrie L. Stock Option
Jun 22, 2022 Buy 65 000 Bourdow Carrie L. Stock Option
Jun 22, 2022 Buy 40 000 Bourdow Carrie L. Common Stock
Jun 01, 2022 Buy 95 500 Ryu Elly Employee Stock Option (Right to Buy)
Feb 18, 2022 Buy 339 525 Sullivan Mark Common Stock
Feb 18, 2022 Buy 86 300 Ryu Elly Common Stock
Feb 18, 2022 Buy 606 800 Cannell Thomas R Common Stock
Feb 18, 2022 Buy 542 250 Forbes Monica Common Stock
Feb 18, 2022 Buy 308 925 Macdonald Glen C Common Stock
Jan 24, 2022 Buy 623 000 Rosales Minori Common Stock
Jan 24, 2022 Buy 0 Rosales Minori
Oct 01, 2021 Buy 115 000 Ryu Elly Common Stock
Jul 20, 2021 Buy 185 000 Jewett Michael A. S. Common Stock
Jul 20, 2021 Buy 0 Jewett Michael A. S.
Jul 20, 2021 Buy 185 000 Honig Peter Stock Option
Jul 20, 2021 Buy 0 Honig Peter
Jun 01, 2021 Buy 1 000 000 Drake Patricia M. Employee Stock Option (Right to Buy)
Jun 01, 2021 Buy 0 Drake Patricia M.
May 03, 2021 Buy 92 500 Henderson Jane Stock Option
May 03, 2021 Buy 92 500 Bourdow Carrie L. Stock Option
May 03, 2021 Buy 92 500 Keyes Jason A Stock Option
May 03, 2021 Buy 92 500 Duker Jay S. Stock Option
Apr 22, 2021 Buy 0 Ryu Elly Common Stock
Apr 22, 2021 Buy 80 000 Ryu Elly Employee Stock Option (Right to Buy)
Feb 19, 2021 Buy 50 000 Anderson Kirstin Employee Stock Option (Right to Buy)
Feb 19, 2021 Buy 300 000 Macdonald Glen C Employee Stock Option (Right to Buy)
Feb 19, 2021 Buy 580 000 Forbes Monica Employee Stock Option (Right to Buy)
Feb 19, 2021 Buy 2 000 000 Cannell Thomas R Employee Stock Option (Right to Buy)
Feb 19, 2021 Buy 300 000 Sullivan Mark Employee Stock Option (Right to Buy)
Jul 01, 2020 Buy 0 Anderson Kirstin Employee Stock Option (Right to Buy)
May 06, 2020 Buy 59 000 Keyes Jason A Stock Option
May 06, 2020 Buy 59 000 Bourdow Carrie L. Stock Option
May 06, 2020 Buy 59 000 Henderson Jane Stock Option
INSIDER POWER
42.276
Last 100 transactions
Buy: 18 724 112 | Sell: 1 428 721 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 42.276.

In total, the insiders bought 18 724 112 and sold 1 428 721 SESN shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Sesen Bio Inc.

Sesen Bio Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscl... SESN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT